Market Overview
U.S. stock futures rose Friday after a new jobs report, as investors looked ahead to a potential Supreme Court decision on tariffs.
Sponsor: Finviz Elite - Looking to spot market movers in real time? Get access to real-time market data, advanced screening filters, and visual market maps with a 7-day free trial.
Indexes & Sectors
Major Indexes: S&P 500 higher, Nasdaq higher, Dow higher, Russell 2000 higher
Leading Sectors: Utilities, Technology, Healthcare, Financial, Energy
Lagging Sectors: -
Economic Calendar
Time (ET) | Report | Actual | Forecast | Previous |
|---|---|---|---|---|
8:30am | U.S. employment report (Dec.) | 50,000 | 73,000 | 64,000 |
8:30am | U.S. unemployment rate (Dec.) | 4.4% | 4.5% | 4.6% |
8:30am | U.S. hourly wages (Dec.) | 0.3% | 0.3% | 0.1% |
8:30am | U.S. hourly wages year over year (Dec.) | 3.8% | 3.6% | 3.5% |
8:30am | U.S. housing starts (Oct.) | 1.25 million units | 1.33 million units | 1.31 million units |
8:30am | U.S. building permits (Oct.) | 1.41 million units | 1.34 million units | 1.31 million units |
10:00am | UMich consumer sentiment (Jan.) | 53.4 | 52.9 | |
10:00am | Minneapolis Fed President Neel Kashkari speaks | |||
1:35pm | Richmond Fed President Tom Barkin speaks |
Stocks In The Spotlight
Cemtrex, Inc. (CETX): Cemtrex completed its acquisition of Invocon, a Texas-based aerospace and defense engineering firm. This deal officially launches Cemtrex’s new Aerospace & Defense segment, giving the company a profitable platform with long-standing relationships with the U.S. government and major defense contractors.
Vistra (VST) & Oklo (OKLO): Vistra and Oklo announced separate agreements to supply nuclear energy to Meta Platforms (META), supporting its large data center campus in Ohio and highlighting growing demand for reliable power from hyperscalers.
Kalvista Pharmaceuticals (KALV): Kalvista reported preliminary fourth-quarter revenue for its drug EKTERLY that came in above expectations. The company continues to show strong momentum across short-, medium-, and long-term trends.
Tilray Brands (TLRY): Tilray reported second-quarter earnings that beat expectations on both revenue and profits. While long-term trends remain positive, near-term performance has been more mixed.
uniQure (QURE): uniQure scheduled a Type A meeting with the U.S. Food and Drug Administration to discuss data supporting accelerated approval of its gene therapy AMT-130 for Huntington’s disease, marking an important regulatory milestone.
ASP Isotopes (ASPI): ASP Isotopes gained investor attention after Meta Platforms signed a long-term nuclear energy supply agreement with TerraPower, reinforcing market interest in nuclear fuel and isotope suppliers.
Insmed (INSM): Insmed reported preliminary 2025 results showing ARIKAYCE revenue exceeded guidance, while BRINSUPRI delivered strong sales in its first full quarter. The company also issued higher revenue guidance for ARIKAYCE in 2026.
Olin (OLN): Olin lowered its fourth-quarter earnings outlook after weaker-than-expected performance, leading to increased investor concern about near-term profitability.
WD-40 (WDFC): WD-40 reported first-quarter earnings and reaffirmed its full-year revenue and profit guidance, signaling stable demand and consistent business performance.
Southwest Airlines (LUV): Southwest Airlines received a positive analyst upgrade from JPMorgan, reflecting improved confidence in the airline’s outlook and long-term strategy.
Aquestive Therapeutics (AQST): The FDA identified deficiencies in Aquestive’s Anaphylm drug application, pausing labeling discussions and potentially delaying approval. The company ended the year with a strong cash position.
General Motors (GM): General Motors announced significant special charges related to restructuring in China and weaker electric vehicle demand. The company is scheduled to report full fourth-quarter earnings later this month.
Intel (INTC): Intel drew attention after President Donald Trump publicly praised the company following a meeting with its CEO, highlighting government support and optimism around Intel’s strategic direction.
Momentum Stocks
(Stocks showing elevated volume and notable price movement)
Gainers: ELVN, BW, SERV, GLUE, GAP, KRUS
Losers: CSIQ, DQ, FVRR, ADSK, JAZZ
Today’s IPOs
Company | Ticker | Managers | Shares | Low | High | Volume |
|---|---|---|---|---|---|---|
Aktis Oncology | AKTS | J.P.Morgan/BofA Securities/Leerink Partners/TD Cowen | 17.7 million | 18.00 | 18.00 | $312.7 million |
Atlas Critical Minerals (Uplisting) | ATCX | A.G.P. (Alliance Global Partners)/Banco Bradesco BBI | 1.2 million | 8.00 | 8.00 | $9.6 million |
Lafayette Digital Acquisition Corp. I | ZKPU | BTIG | 25.0 million | 10.00 | 10.00 | $250.0 million |
Disclaimer: This newsletter is for informational purposes only and does not constitute investment advice. Readers should conduct their own research and consider consulting a financial professional before making investment decisions.